Higher levels of BCL-2 relative to MCL-1 have been reported in association with t(11;14) MM; a feature associated with increased sensitivity to the BCL-2 inhibitor venetoclax [44, 45]. The gene discussed is MCL1; the disease is Miyoshi myopathy.